Published in Transplantation on October 01, 1971
FK506 suppression of heart and liver allograft rejection. II: The induction of graft acceptance in rats. Transplantation (1990) 2.13
Mechanisms maintaining enhancement of allografts. I. Demonstration of a specific suppressor cell. J Exp Med (1985) 0.99
Cellular immune responses to methylcholanthrene-induced fibrosarcoma in BALB/c mice. J Exp Med (1975) 0.84
Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: similarity of L3T4 to the human Leu-3/T4 molecule. J Immunol (1983) 14.36
IgG or IgM monoclonal antibodies reactive with different determinants on the molecular complex bearing Lyt 2 antigen block T cell-mediated cytolysis in the absence of complement. J Immunol (1980) 10.30
Anti-proliferative effect of IFN-gamma in immune regulation. I. IFN-gamma inhibits the proliferation of Th2 but not Th1 murine helper T lymphocyte clones. J Immunol (1988) 5.80
Suggestive evidence that the "blocking antibodies" of tumor-bearing individuals may be antigen--antibody complexes. Proc Natl Acad Sci U S A (1971) 5.38
Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4. Cell (1992) 4.34
Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors. Nat Med (1997) 3.89
Antiproliferative effect of IFN-gamma in immune regulation. III. Differential selection of TH1 and TH2 murine helper T lymphocyte clones using recombinant IL-2 and recombinant IFN-gamma. J Immunol (1989) 3.78
Cellular immunity against tumor antigens. Adv Cancer Res (1969) 3.70
Murine Th1 and Th2 clones proliferate optimally in response to distinct antigen-presenting cell populations. J Immunol (1991) 3.44
Abrogation of cellular immunity to antigenically foreign mouse embryonic cells by a serum factor. Nature (1969) 3.20
Immunological enhancement as studied by cell culture techniques. Annu Rev Microbiol (1970) 3.12
Blocking of cell-mediated tumor immunity by sera from patients with growing neoplasms. Int J Cancer (1971) 3.06
Cloned T lymphocytes and monoclonal antibodies as probes for cell surface molecules active in T cell-mediated cytolysis. Immunol Rev (1982) 3.06
Alloreactive cloned T cell lines. I. Interactions between cloned amplifier and cytolytic T cell lines. J Exp Med (1980) 3.00
Demonstration of cell-mediated immunity to human neoplasms of various histological types. Int J Cancer (1971) 2.88
Soluble member(s) of the mesothelin/megakaryocyte potentiating factor family are detectable in sera from patients with ovarian carcinoma. Proc Natl Acad Sci U S A (1999) 2.87
Studies on cellular immunity and its serum mediated inhibition in Moloney-virus-induced mouse sarcomas. Int J Cancer (1969) 2.80
Lymphocyte-mediated cytotoxicity and blocking serum activity to tumor antigens. Adv Immunol (1974) 2.68
Superoxide-dependent formation of hydroxyl radicals in the presence of iron salts. Detection of 'free' iron in biological systems by using bleomycin-dependent degradation of DNA. Biochem J (1981) 2.68
The specific selection of recirculating lymphocytes by antigen in normal and preimmunized rats. J Exp Med (1972) 2.66
Blocked Ras activation in anergic CD4+ T cells. Science (1996) 2.64
Cellular and humoral immunity to different types of human neoplasms. Nature (1968) 2.40
Cell surface antigens of human melanoma identified by monoclonal antibody. Proc Natl Acad Sci U S A (1979) 2.40
Serum-mediated protection of neoplastic cells from inhibition by lymphocytes immune to their tumor-specific antigens. Proc Natl Acad Sci U S A (1969) 2.28
Phosphorylation of synthetic peptides by a tyrosine protein kinase from the particulate fraction of a lymphoma cell line. Proc Natl Acad Sci U S A (1982) 2.25
Aneurysmal bone cysts. A clinicopathologic study of 66 cases. Cancer (1970) 2.20
Orthotopic autotransplantation and allotransplantation of the liver: functional and structural patterns in the dog. Ann Surg (1967) 2.17
Identification of a cell surface protein, p97, in human melanomas and certain other neoplasms. Proc Natl Acad Sci U S A (1980) 2.14
Demonstration of cell-bound and humoral immunity against neuroblastoma cells. Proc Natl Acad Sci U S A (1968) 2.12
The rate of division of antibody-forming cells during the early primary immune response. J Exp Med (1968) 2.10
Regulation of T-cell activation: differences among T-cell subsets. Immunol Rev (1989) 2.08
Homeostasis of the antibody response: immunoregulation by NK cells. Science (1983) 2.04
A highly immunogenic tumor transfected with a murine transforming growth factor type beta 1 cDNA escapes immune surveillance. Proc Natl Acad Sci U S A (1990) 2.03
Synergy between T-cell immunity and inhibition of paracrine stimulation causes tumor rejection. Proc Natl Acad Sci U S A (1995) 1.94
Tumor immunogenicity determines the effect of B7 costimulation on T cell-mediated tumor immunity. J Exp Med (1994) 1.93
Evidence implicating utilization of different T cell receptor-associated signaling pathways by TH1 and TH2 clones. J Immunol (1990) 1.84
T-cell lines which cooperate in generation of specific cytolytic activity. Nature (1979) 1.82
Stroma is critical for preventing or permitting immunological destruction of antigenic cancer cells. J Exp Med (1992) 1.81
Changes in heroin self-administration by a rhesus monkey after morphine immunisation. Nature (1974) 1.81
Murine T lymphocyte clones with distinct immunological functions. Immunol Rev (1981) 1.79
Alloreactive cloned T cell lines. VI. Multiple lymphokine activities secreted by helper and cytolytic cloned T lymphocytes. J Immunol (1982) 1.78
CD28 costimulation promotes the production of Th2 cytokines. J Immunol (1997) 1.78
Elution of "blocking factors" from human tumors, capable of abrogating tumor-cell destruction by specifically immune lymphocytes. Int J Cancer (1972) 1.76
The x-ray structure of an anti-tumour antibody in complex with antigen. Nat Struct Biol (1995) 1.76
Monoclonal mouse antibodies raised against human lung carcinoma. Cancer Res (1986) 1.75
Rejection of renal allografts: specific immunologic suppression. Science (1968) 1.73
In vitro studies of immune reactions against autochthonous and syngeneic mouse tumors induced by methylcholanthrene and plastic discs. Int J Cancer (1968) 1.73
Superoxide-dependent formation of hydroxyl radicals and lipid peroxidation in the presence of iron salts. Detection of 'catalytic' iron and anti-oxidant activity in extracellular fluids. Biochem J (1982) 1.72
Quantitative analysis of melanoma-associated antigen p97 in normal and neoplastic tissues. Proc Natl Acad Sci U S A (1981) 1.70
Dendritic cells that have interacted with antigen are targets for natural killer cells. J Exp Med (1985) 1.68
Specific suppression of immune responses. Science (1973) 1.67
Immunological tolerance: "forbidden clones" allowed in tetraparental mice. Proc Natl Acad Sci U S A (1971) 1.67
Monoclonal antibodies to estrophilin: probes for the study of estrogen receptors. Proc Natl Acad Sci U S A (1980) 1.66
Monoclonal antibody to L3T4 blocks the function of T cells specific for class 2 major histocompatibility complex antigens. J Immunol (1984) 1.62
Cellular localization of latent murine cytomegalovirus. J Virol (1998) 1.62
Chimeric mouse-human IgG1 antibody that can mediate lysis of cancer cells. Proc Natl Acad Sci U S A (1987) 1.61
Neonatal tolerance induced by antibody against antigen-specific receptor. Science (1974) 1.61
"Anergy" of TH0 helper T lymphocytes induces downregulation of TH1 characteristics and a transition to a TH2-like phenotype. J Exp Med (1994) 1.60
Anti-idiotypic antibody in rat transplantation immunity. I. Production of anti-idiotypic antibody in animals repeatedly immunized with alloantigens. J Immunol (1974) 1.59
Costimulation of T cells for tumor immunity. Immunol Today (1993) 1.57
Highly tumor-reactive, internalizing, mouse monoclonal antibodies to Le(y)-related cell surface antigens. Cancer Res (1990) 1.57
Cellular deficit in thymectomized mice. Nature (1970) 1.57
Cellular immunity and its serum-mediated inhibition in Shope-virus-induced rabbit papillomas. Int J Cancer (1969) 1.56
Properties of rat anti-MHC antibodies produced by cloned rat-mouse hybridomas. Immunol Rev (1979) 1.54
Distribution of immunoglobulins in human rectal mucosa. II. Ulcerative colitis and abnormal mucosal control subjects. Gastroenterology (1968) 1.49
Identification and propagation of a putative immunosuppressive orphan parvovirus in cloned T cells. J Immunol (1993) 1.49
A clone-specific monoclonal antibody that inhibits cytolysis of a cytolytic T cell clone. J Exp Med (1983) 1.48